Correlation Between Anebulo Pharmaceuticals and Accustem Sciences

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Accustem Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Accustem Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and Accustem Sciences, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Accustem Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Accustem Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Accustem Sciences.

Diversification Opportunities for Anebulo Pharmaceuticals and Accustem Sciences

0.6

Correlation Coefficient

Anebulo Pharmaceuticals  Accustem Sciences

Poor diversification

The 3 months correlation between Anebulo and Accustem is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Accustem Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accustem Sciences and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Accustem Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accustem Sciences has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Accustem Sciences go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Accustem Sciences

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Accustem Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 2.14 times less risky than Accustem Sciences. The stock trades about -0.01 of its potential returns per unit of risk. The Accustem Sciences is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  24.00  in Accustem Sciences on December 30, 2024 and sell it today you would earn a total of  28.00  from holding Accustem Sciences or generate 116.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	95.38%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  Accustem Sciences

Anebulo Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Accustem Sciences

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Accustem Sciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Accustem Sciences unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anebulo Pharmaceuticals and Accustem Sciences

The main advantage of trading using opposite Anebulo Pharmaceuticals and Accustem Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Accustem Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accustem Sciences will offset losses from the drop in Accustem Sciences' long position.

The idea behind Anebulo Pharmaceuticals and Accustem Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.